Literature DB >> 23019679

Compared to conventional ventilation, airway pressure release ventilation may increase ventilator days in trauma patients.

Adrian A Maung1, Kevin M Schuster, Lewis J Kaplan, Michael F Ditillo, Greta L Piper, Linda L Maerz, Felix Y Lui, Dirk C Johnson, Kimberly A Davis.   

Abstract

BACKGROUND: Airway pressure release ventilation (APRV) is used both as a rescue therapy for patients with acute lung injury and as a primary mode of ventilation. Unlike assist-control volume (ACV) ventilation that uses spontaneous breathing trials, APRV weaning consists of gradual decreases in supporting pressure. We hypothesized that the APRV weaning process increases total ventilator days compared with those of spontaneous breathing trials-based weaning.
METHODS: A retrospective review of a Level I trauma center's database identified trauma admissions from January 1, 2007, to December 31, 2010, which required mechanical ventilation for more than 24 hours and survived. Demographics, injuries, in-hospital complications, ventilation mode(s), and total ventilator days were abstracted.
RESULTS: A total of 362 patients fulfilled study entry criteria; 53 patients with more than one ventilator mode change were excluded. Seventy-five patients were successfully liberated from mechanical ventilation on APRV and 234 on ACV. The APRV and ACV groups, respectively, were similar in age (46.1 vs. 44.6 years) and sex (72% vs. 73% male) but differed in Injury Severity Score (20.8 vs. 17.5; p = 0.03). Patients on APRV had higher rates of abdominal compartment syndrome (6.7% vs. 0.8%, p = 0.003) and were more likely to have a higher chest Abbreviated Injury Scale (AIS) score ≥3 (57.3% vs. 30.8%, p < 0.001). Ventilator days were significantly greater in the APRV group (19.6 vs. 10.7 days, p < 0.001). Multiple regression was performed to adjust for the clinical differences between the two groups, identifying APRV as an independent predictor for increased number of ventilator days (B = 6.2 ± 1.5, p < 0.001) in addition to male sex, abdomen AIS score of 3 or higher, spine AIS score of 3 or higher, acute renal failure, and sepsis.
CONCLUSION: APRV is frequently used for patients who are more severely injured or who develop in-hospital complications such as pneumonia. However, after controlling for potential confounding factors in a multiple regression model, the APRV mode itself seems to increase ventilator days.

Entities:  

Mesh:

Year:  2012        PMID: 23019679     DOI: 10.1097/ta.0b013e31825ff653

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  The authors reply.

Authors:  Vikram Fielding-Singh; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2019-04       Impact factor: 7.598

2.  Airway pressure release ventilation (APRV): do good things come to those who can wait?

Authors:  Thomas Bein; Hermann Wrigge
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 3.  Salvage therapies for refractory hypoxemia in ARDS.

Authors:  Sujith V Cherian; Anupam Kumar; Karunakar Akasapu; Rendell W Ashton; Malaygiri Aparnath; Atul Malhotra
Journal:  Respir Med       Date:  2018-07-03       Impact factor: 3.415

4.  Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome.

Authors:  Yongfang Zhou; Xiaodong Jin; Yinxia Lv; Peng Wang; Yunqing Yang; Guopeng Liang; Bo Wang; Yan Kang
Journal:  Intensive Care Med       Date:  2017-09-22       Impact factor: 17.440

Review 5.  The 30-year evolution of airway pressure release ventilation (APRV).

Authors:  Sumeet V Jain; Michaela Kollisch-Singule; Benjamin Sadowitz; Luke Dombert; Josh Satalin; Penny Andrews; Louis A Gatto; Gary F Nieman; Nader M Habashi
Journal:  Intensive Care Med Exp       Date:  2016-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.